Tencent TME Delivers Q1 2026 Beat EPS 146 vs 144 Expected Hennessy Advisors HNNA Flat at 984 Consolidation Continues 20260514 Amneal AMRX Q1 2026 Earnings Beat Revenue NA EPS 027 Iran Conflict Exposes Critical Vulnerabilities in AI Chip Supply Chain PAGS Q1 2026 Earnings EPS Misses Estimates Amid Flat Stock Response Chris Hohn How Conviction in Finance Philanthropy and Faith Built a RecordBreaking Hedge Fund Martin Midstream Partners LP MMLP Hovers Near Support as Slight Decline Persists JPMorgan Boosts Price Target for Hewlett Packard Enterprise Amid AI Infrastructure Demand SpaceX Scrubs 12th Starship Test Flight Schedules Retry for Friday Amid Program Milestones AI Drug Discovery Poised to Accelerate Treatments for Brain Conditions Like MND Mamaearth and LIC Lead Fridays Stock Movers Among Top Gainers and Losers Trump Targets Republican Opponents Over 18 Billion AntiWeaponisation Fund Surging Gas Prices Hit LowerIncome Households Harder New York Fed Study Suggests General Motors Introduces AllElectric Cadillac Vistiq With 300Mile Range POWI Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Uncertainty Gap Inc GAP Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Uptick BK Q1 2026 Earnings Strong EPS Surprise of 1326 Amid Stable Market Response CCNEP Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline SPGI Q1 2026 Earnings Earnings Beat Estimates Despite Modest Stock Reaction X Faces Regulatory Penalty in Australia Over Child Safety Compliance Retail Traders and HNIs Push Stock Futures to Record Levels Amid Midcap Rally Huawei Unveils New Chip Design Technology Amid US Restrictions Competition with Nvidia Apple Intensifies Alex Warrens Ordinary Extends Billboard Reign Setting a New Chart Record American Express National Bank Expands Beyond Credit Cards with HighYield Accounts and NoFee Banking for 2026 Chinas Crypto Crackdown Faces Growing Challenges from Underground Middlemen April Jobs Report Preview Labor Market Cooling Yet Resilient Amid Economic Challenges CGTX Q1 2026 Earnings Narrower Loss Exceeds Estimates as PreRevenue Biotech Advances Pipeline